This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, Bałdys-Waligórska A, Bednarczuk T, Bolanowski M et al.: Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 79–110.Kos-KudłaBBlicharz-DorniakJStrzelczykJBałdys-WaligórskaABednarczukTBolanowskiM:Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).Endokrynol Pol2017;68:79–110.10.5603/EP.2017.001528597909Search in Google Scholar
Bodei L, Sundin A, Kidd M, Prasad V, Modlin IM: The status of neuroendocrine tumor imaging: from darkness to light? Neuroendocrinology 2015; 101: 1–17.BodeiLSundinAKiddMPrasadVModlinIM:The status of neuroendocrine tumor imaging: from darkness to light?Neuroendocrinology2015;101:1–17.10.1159/00036785025228173Search in Google Scholar
Maxwell JE, Howe JR: Imaging in neuroendocrine tumors: an update for the clinician. Int J Endocr Oncol 2015; 2: 159–168.MaxwellJEHoweJR:Imaging in neuroendocrine tumors: an update for the clinician.Int J Endocr Oncol2015;2:159–168.10.2217/ije.14.40452614126257863Search in Google Scholar
Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA: Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 2013; 266: 38–61.SahaniDVBonaffiniPAFernández-Del CastilloCBlakeMA:Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management.Radiology2013;266:38–61.10.1148/radiol.1211251223264526Search in Google Scholar
Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC: Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer 2008; 123: 867–873.HassanMMPhanALiDDagohoyCGLearyCYaoJC:Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.Int J Cancer2008;123:867–873.10.1002/ijc.2352918491401Search in Google Scholar
Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM: The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 2011; 40: 1–18.LawrenceBGustafssonBIChanASvejdaBKiddMModlinIM:The epidemiology of gastroenteropancreatic neuroendocrine tumors.Endocrinol Metab Clin North Am2011;40:1–18.10.1016/j.ecl.2010.12.00521349409Search in Google Scholar
Toumpanakis CG, Caplin ME: Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Am J Gastroenterol 2008; 103: 729–732.ToumpanakisCGCaplinME:Molecular genetics of gastroenteropancreatic neuroendocrine tumors.Am J Gastroenterol2008;103:729–732.10.1111/j.1572-0241.2007.01777.x18341492Search in Google Scholar
Shehata BM, Stockwell CA, Castellano-Sanchez AA, Setzer S, Schmotzer CL, Robinson H: Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects. Adv Anat Pathol 2008; 15: 165–171.ShehataBMStockwellCACastellano-SanchezAASetzerSSchmotzerCLRobinsonH:Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects.Adv Anat Pathol2008;15:165–171.10.1097/PAP.0b013e31816f852e18434768Search in Google Scholar
Lodish MB, Stratakis CA: Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab 2010; 24: 439–449.LodishMBStratakisCA:Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes.Best Pract Res Clin Endocrinol Metab2010;24:439–449.10.1016/j.beem.2010.02.002293906120833335Search in Google Scholar
Tsujimura K, Takushi Y, Teruya T, Iha K, Ota M, Nakachi A et al.: Neuroendocrine tumor of the small intestine diagnosed with trans-abdominal ultrasonography: A case report. Int J Surgery Case Reports 2017; 31: 75–78.TsujimuraKTakushiYTeruyaTIhaKOtaMNakachiA:Neuroendocrine tumor of the small intestine diagnosed with trans-abdominal ultrasonography: A case report.Int J Surgery Case Reports2017;31:75–78.10.1016/j.ijscr.2017.01.012525718528122317Search in Google Scholar
Miller HC, Frampton AE, Malczewska A, Ottaviani S, Stronach EA, Flora R et al.: MicroRNAs associated with small bowel neuroendocrine tumours and their metastases. Endocr Relat Cancer 2016; 23: 711–726.MillerHCFramptonAEMalczewskaAOttavianiSStronachEAFloraR:MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.Endocr Relat Cancer2016;23:711–726.10.1530/ERC-16-004427353039Search in Google Scholar
Bednarczuk T, Bolanowski M, Zemczak A, Bałdys-Waligórska A, Blicharz-Dorniak J, Boratyn-Nowicka A et al.: Neuroendocrine neoplasms of the small intestine and the appendix – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 223–236.BednarczukTBolanowskiMZemczakABałdys-WaligórskaABlicharz-DorniakJBoratyn-NowickaA:Neuroendocrine neoplasms of the small intestine and the appendix – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).Endokrynol Pol2017;68:223–236.10.5603/EP.2017.001828540974Search in Google Scholar
Tan EH, Tan CH: Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2011; 2: 28–43.TanEHTanCH:Imaging of gastroenteropancreatic neuroendocrine tumors.World J Clin Oncol2011;2:28–43.10.5306/wjco.v2.i1.28309546321603312Search in Google Scholar
Kong WT, Ji ZB, Wang WP, Cai H, Huang BJ, Ding H: Evaluation of liver metastases using contrast-enhanced ultrasound: enhancement patterns and influencing factors. Gut Liver 2016; 10: 283–287.KongWTJiZBWangWPCaiHHuangBJDingH:Evaluation of liver metastases using contrast-enhanced ultrasound: enhancement patterns and influencing factors.Gut Liver2016;10:283–287.10.5009/gnl14324478045926586554Search in Google Scholar
Braden B, Jenssen Ch, D’Onofrio M, Hocke M, Will U, Möller K et al.: B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors. Endosc Ultrasound 2017; 6: 49–54.BradenBJenssenChD’OnofrioMHockeMWillUMöllerK:B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors.Endosc Ultrasound2017;6:49–54.10.4103/2303-9027.200213533184428218201Search in Google Scholar
Dietrich CF, Ignee A, Braden B, Barreiros AP, Ott M, Hocke M: Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008; 6: 590–597.DietrichCFIgneeABradenBBarreirosAPOttMHockeM:Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound.Clin Gastroenterol Hepatol2008;6:590–597.10.1016/j.cgh.2008.02.03018455699Search in Google Scholar
Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M et al.: Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastroentero-pancreatic tumours. Eur J Nucl Med 1998; 25: 1396–1403.ChitiAFantiSSavelliGRomeoABellanovaBRodariM:Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastroentero-pancreatic tumours.Eur J Nucl Med1998;25:1396–1403.10.1007/s0025900503149818279Search in Google Scholar
Kos-Kudła B, Rosiek V, Borowska M, Bałdys-Waligórska A, Bednarczuk T, Blicharz-Dorniak J et al.: Pancreatic neuroendocrine neoplasms – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 169–197.Kos-KudłaBRosiekVBorowskaMBałdys-WaligórskaABednarczukTBlicharz-DorniakJ:Pancreatic neuroendocrine neoplasms – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).Endokrynol Pol2017;68:169–197.10.5603/EP.2017.201628540973Search in Google Scholar
Starzyńska T, Londzin-Olesik M, Bałdys-Waligórska A, Bednarczuk T, Blicharz-Dorniak J, Bolanowski M et al.: Colorectal neuroendocrine neoplasms – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 250–260.StarzyńskaTLondzin-OlesikMBałdys-WaligórskaABednarczukTBlicharz-DorniakJBolanowskiM:Colorectal neuroendocrine neoplasms – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).Endokrynol Pol2017;68:250–260.10.5603/EP.2017.001928540975Search in Google Scholar
Sun Bo, Hu B: The role of intraductal ultrasonography in pancreatobiliary diseases. Endosc Ultrasound 2016; 5: 291–299.SunBoHuB:The role of intraductal ultrasonography in pancreatobiliary diseases.Endosc Ultrasound2016;5:291–299.10.4103/2303-9027.191607507028627803901Search in Google Scholar
Nemakayala D, Patel P, Rahimi E, Fallon MB, Thosani N: Use of quantitative endoscopic ultrasound elastography for diagnosis of pancreatic neuroendocrine tumors. Endosc Ultrasound 2016; 5: 342–345.NemakayalaDPatelPRahimiEFallonMBThosaniN:Use of quantitative endoscopic ultrasound elastography for diagnosis of pancreatic neuroendocrine tumors.Endosc Ultrasound2016;5:342–345.10.4103/2303-9027.191680507029427803909Search in Google Scholar
Iglesias-Garcia J, Larino-Noia J, Abdulkader I, Forteza J, Dominguez-Munoz JE: Quantitative endoscopic ultrasound elastography: An accurate method for the differentiation of solid pancreatic masses. Gastroenterology 2010; 139: 1172–1180.Iglesias-GarciaJLarino-NoiaJAbdulkaderIFortezaJDominguez-MunozJE:Quantitative endoscopic ultrasound elastography: An accurate method for the differentiation of solid pancreatic masses.Gastroenterology2010;139:1172–1180.10.1053/j.gastro.2010.06.05920600020Search in Google Scholar